Market Overview

UPDATE: Morgan Stanley Reiterates On Walgreen Company As Inversion Debate Continues

Related WAG
Top 4 Stocks In The Drug Stores Industry With The Highest Dividend Yield
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Will the Prez Call Out…The Oracle? (Fox Business)

In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $75.00 price target.

In the report, Morgan Stanley noted, “Political debate intensifying around high profile tax inversion deals adding to the uncertainty around the plausibility of inversion for WAG. While prospects for inversion have been a key debate for WAG shares, we see opportunities for the combined WAG/AB to lower tax rate and expand margins independent of a corporate inversion.”

Walgreen Company closed on Friday at $68.66.

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (WAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters